By contrast, for non-APOE4 carriers, the I allele, which increases CETP and decreases HDL, was associated with greater baseline thickness and lower dementia risk, suggesting that APOE genotype may modify the impact of CETP polymorphisms on neurodegeneration and cognitive decline [139]. This evidence concerns the gene CETP and Mental deterioration.